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Systems for in vitro culture of Hepatitis C virus (HCV) are essential tools to analyse virus–cell
interactions and to investigate relevant pathophysiological aspects of HCV infection. Although the
HCV replicon methodology has increased our understanding of HCV biology, this system
does not reproduce the natural infection. Recently, tupaia (Tupaia belangeri chinensis) hepatocytes
have been utilized for in vitro culture of HCV. In the present work, primary tupaia hepatocytes
infected in vitro with HCV were used to analyse the evolution of HCV quasispecies in infected cells
and the ability of the virus to influence antiviral and proinflammatory responses in cells
sustaining virus replication. The results confirmed the potential of tupaia hepatocytes as a
model for HCV infection, although this system is limited by rapid loss of differentiated cell phenotype
in culture. These findings revealed an extraordinary plasticity of HCV quasispecies, which
underwent rapid evolution to tupaia-tropic variants as early as 24 h after infection. It was also shown
that HCV could activate interferon-sensitive genes, albeit modestly in comparison with other
viruses such as Semliki Forest virus. Importantly, HCV activated NF-kB in primary hepatocytes
and upregulated NF-kB-responsive genes including the chemokines MCP-1 and CXCL2 (MIP-2).
This effect may play a role in induction of the hepatic inflammatory reaction in vivo. In summary,
HCV quasispecies adapt rapidly to the specific biology of the host and HCV stimulates a
blunted interferon response while inducing a proinflammatory phenotype in the infected cell.
INTRODUCTION
Hepatitis C virus (HCV) is a positive-strand RNA virus
belonging to the genus Hepacivirus within the family
Flaviviridae. The majority of HCV-infected individuals
develop chronic hepatitis, which may progress to liver
cirrhosis and hepatocellular carcinoma. Six major genotypes
(1–6) and multiple minor subtypes have been described
(Robertson et al., 1998). Moreover, due to an error-prone
RNA polymerase that causes a high mutation rate, HCV
circulates as a heterogeneous population (Forns et al., 2000)
of closely related variants termed quasispecies (Manzin
et al., 1998). These variants are subjected to host immune
pressure, which does not affect all viral proteins uniformly.
Genetic variability is segregated within particular segments
of the HCV genome, resulting in a number of highly variable
regions. The most variable region is hypervariable region 1
(HVR1) of the E2 glycoprotein (Weiner et al., 1991).
The biological significance of the viral diversity is not clear,
but differences in pathogenesis, cell tropism, viral persis-
tence and response to therapy have been reported (Farci &
Purcell, 2000; Lopez-Labrador et al., 1999; Pessoa et al.,
1999). Combined therapy with pegylated interferon plus
ribavirin induces a sustained viral elimination in more than
80 % of patients infected with genotypes 2 and 3, but in less
than 50 % of those infected with genotypes 1 and 4. Due to
the high prevalence of genotype 1, there is an urgent need
to develop new anti-HCV drugs and therapeutic strategies.
Animal models of HCV infection and systems for in vitro
HCV culture are essential tools for an understanding of
HCV biology and virus–host interactions and to identify
new therapeutic targets. The chimpanzee is the only
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non-human host for HCV infection, but the use of these
animals is restricted due to problematic availability, high
maintenance costs, ethical considerations and regulations
banning the use of this species for many experimental
studies. Recently, subgenomic and genomic HCV replicons
have been increasingly used to study the cellular effects of
HCV replication (Bukh et al., 2002; Lohmann et al., 1999).
However, although these systems have allowed a better
understanding of HCV biology, they do not serve as true
models of HCV infection (Su et al., 2002). Systems based on
infection of primary cells in culture have been described.
Susceptibility of human haematopoietic cells (dendritic
cells, peripheral blood mononuclear cells and macrophages)
has been reported (Cribier et al., 1995; Navas et al., 2002;
Radkowski et al., 2004), but these systems suffer from poor
reproducibility and very low levels of HCV replication.
Other groups have used primary hepatocytes from humans
or chimpanzees (Fournier et al., 1998; Lanford et al., 1994;
Rumin et al., 1996), but the limited availability of these cells
makes these systems impractical for routine use. Very
recently, a virus production system that allows secretion of
viral particles has been developed (Wakita et al., 2005). The
system is based on an HCV 2a clone and Huh-7-derived
cell lines and holds considerable promise for the study of
virus–host interactions and for testing antiviral compounds
and vaccines. However, an important limitation of this
culture system is that it only contains RNA from one of the
six HCV genotypes.
Some reports have shown that the tree shrew or tupaia
(Tupaia belangeri) is susceptible to infection in vivo with
human hepatitis viruses such as hepatitis A, B and delta
virus (Li et al., 1995; Walter et al., 1996; Yan et al., 1996;
Zhan et al., 1981). Tupaias are small squirrel-like animals
(~150 g) endemic to South-East Asia that are closely related
to primates and classified in their own order (Scandentia)
(Martin, 1990). Studies from our group have shown that one
subspecies of these animals (Tupaia belangeri chinensis) is
partially susceptible to HCV infection after immunosup-
pression and subsequent intravenous inoculation of infec-
tious HCV sera (Xie et al., 1998). Moreover, recent papers
have demonstrated that tupaia primary hepatocytes can be
infected in vitro with HCV (Barth et al., 2005; Zhao et al.,
2002). In the present study, we assessed the potential of
cultured tupaia hepatocytes as a system for culturing HCV
in vitro and used this model to analyse the evolution of
HCV quasispecies and the ability of the virus to influence
the antiviral and proinflammatory response in the infected
cell.
METHODS
Animals. Adult tupaias (T. belangeri chinensis) were kept in the
animal facilities of the University of Navarra (Spain) in steel cages at
a temperature of 26±2 uC, with a relative humidity of 50–70 % and
a 12/12 h light/dark cycle. Handling and care of the tupaias were
evaluated and approved by the Animal Ethical Committee of the
University of Navarra.
Isolation and culture of primary hepatocytes. Tupaias were
anaesthetized by intramuscular injection with a mixture of ketamine,
xylazine and atropine (16 mg, 0?75 mg and 3 mg per 100 g body
weight, respectively). Hepatocytes were isolated through a two-
step collagenase liver perfusion procedure employing 50–70 mg
Hepatocyte Qualified Collagenase (Gibco-BRL) for 10–15 min. The
viability of isolated cells was assessed by the trypan blue exclusion
test. Dead cells were removed on a 40 % Percoll (Amersham
Pharmacia) gradient and hepatocytes were seeded at confluence
(1?2–1?56106 cells per well) on collagen-covered, six-well plates
(Becton Dickinson) allowing overnight attachment of the cells. After
seeding, cells were maintained in 2 ml Williams’ E medium with
GlutaMAX-I (Gibco-BRL) supplemented with 100 U penicillin and
streptomycin ml21 (Gibco-BRL), 5 mg bovine insulin (Sigma) l21,
2 % DMSO (Sigma), 3?56105 M hydrocortisone hemisuccinate
(Sigma) and 2 % AB normal human serum (BioWhittaker) (Rumin
et al., 1999). Cells were incubated at 37 uC in a humidified atmo-
sphere of 5 % CO2 and the medium was changed every 2–3 days. As
a negative control, primary rat hepatocytes were isolated and cultured
using a similar procedure to that described for tupaia hepatocytes.
In vitro infection of primary hepatocytes. Hepatocytes were
infected 1 day after plating by overnight incubation of cells with
50 ml of different human infectious sera in 1 ml medium without
AB normal human serum per well. The inoculum was then removed
and the cells were washed five to six times with PBS (Gibco-BRL)
and finally refed with medium. HCV mock-infected cells were incu-
bated with 50 ml human non-infectious serum. Hepatocytes from
three rats were infected under exactly the same conditions as tupaia
hepatocytes. Supernatants and hepatocytes were collected at various
time points during the culture.
All infectious serum samples used belonged to patients that were non-
responders to interferon therapy, presented a high titre of HCV RNA
(107–109 IU ml21) genotype 1 and were negative for hepatitis B virus
and human immunodeficiency virus markers.
In one experiment, hepatocytes were infected with Semliki Forest virus
(SFV) (Liljestrom & Garoff, 1991) at an m.o.i. of 45. Cells were
incubated with virus for 6 h, washed twice with PBS and finally refed
with medium.
Harvest of samples and RNA extraction. For collection of hepa-
tocytes, cells from one well were washed twice with PBS and then
scraped, pelleted and stored at 280 uC in 500 ml using the Ultraspec
RNA Isolation system (Biotecx Laboratories). Supernatants were also
collected and stored at 280 uC.
RNA was purified from 500 ml supernatant or from cells contained in
one well or from 100 ml infectious inocula using the Ultraspec RNA
Isolation system according to the manufacturer’s instructions. RNA
was resuspended in 20 ml DEPC-treated water, quantified by
measurement of absorbance and stored at 280 uC. In some cases, a
double RNA extraction was performed.
cDNA synthesis. For reverse transcription, a quarter of the RNA
extracted was first denatured for 1 min at 90 uC. cDNA synthesis
was then performed for 1 h at 37 uC in a reaction mixture contain-
ing 60 U Moloney murine leukaemia virus reverse transcriptase
(MMLV RT; Gibco-BRL), RT buffer, 5 mM dithiothreitol, 2 mM
dNTP mix (Roche Molecular Biochemicals), 100 ng random primers
(Roche Molecular Biochemicals) and 12 U RNase inhibitor
(Promega) in a final volume of 10 ml.
Detection of genomic HCV RNA by nested RT-PCR.
Supernatants and hepatocytes were analysed to detect genomic HCV
RNA by nested PCR from the 59 non-coding region (59NCR). Outer
primers used were JL1 (sense): 59-CCTGTGAGGAACTACTGTCT-39
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and JL2 (antisense): 59-CTATCAGGCAGTACCACAAG-39. Inner
primers were JL3 (sense): 59-ACTGTCTTCACGCAGAAAGC-39 and
JL4 (antisense): 59-GACCCAACACTACTCGGCTA-39. PCR condi-
tions for both rounds consisted of an initial denaturation of 95 uC
for 1 min, followed by 35 cycles of 95 uC for 15 s, 52 uC for 12 s and
72 uC for 20 s, and a final extension of 72 uC for 1 min. Reactions
were carried out with 3 ml cDNA or first-round PCR product, 1 U
Expand High Fidelity Taq DNA polymerase (Roche Diagnostics),
1?5 mM MgCl2, 0?8 mM dNTP mix and 0?5 mM inner or outer pri-
mers in a final volume of 20 ml. All genomic HCV detection assays
included negative controls consisting of mock-infected tupaia cells
and water. RNA isolated from HCV-positive serum was used as a
positive control. The sensitivity of the assay was 102 RNA copies.
Detection of negative-strand HCV by strand-specific recom-
binant (r)Tth RT-PCR assay. Specific detection of negative-strand
HCV RNA was performed using the rTth RT-PCR method described
by Lanford et al. (1995) with some modifications. Briefly, a 10 ml RT
reaction containing 0?5–1 mg RNA was performed at 70 uC with
0?75 mM 59NCR sense primer (JL3) and 5 U rTth DNA polymerase
(Applied Biosystems). After addition of chelating buffer, still at
70 uC, the PCR mixture (2 mM MgCl2 and 0?15 mM JL2 antisense
primer) was added. PCR conditions consisted of an initial denatura-
tion of 94 uC for 1 min, followed by 35 cycles of 94 uC for 20 s,
60 uC for 30 s and 72 uC for 30 s, and a final extension at 72 uC for
7 min. A second PCR round was required to detect visible bands.
For the nested PCR, 3 ml first-round PCR product was reamplified
using the primers JL3 and JL4 as described above.
To assess the sensitivity and specificity of the method, synthetic posi-
tive and negative strands of HCV RNA encompassing the 59NCR were
transcribed in vitro to be used as standards in our assay. HCV RNA
transcripts were synthesized from a PCR II TOPO vector (TOPO TA
Cloning kit; Invitrogen) containing the insert JL1–JL2 of HCV 59NCR
sequence using either T7 (Roche Molecular Biochemicals) or SP6
(Amersham Pharmacia) RNA polymerase. RNA transcripts were
treated twice with DNase I (Gibco-BRL). The absence of residual DNA
template was ascertained by performing nested PCR without the RT
step of both transcripts (from 107 to 1010 RNA copies). Dilutions of
synthetic RNA were made in control liver RNA to mimic conditions in
hepatocytes.
Quasispecies analysis. For sequence analysis of HCV HVR1,
RNA purified from infectious inocula and tupaia hepatocytes was
amplified by reverse transcription and the nested PCR procedure
with primers derived from the E2 region. Outer primers used were
HV1 (sense) and HV2 (antisense) (Lanford et al., 1995) and the
inner degenerate primers were HV3 (sense): 59-TGGTGGGGAA-
CTGGGCYAAGGT-39, and HV6 (antisense): 59-ARGGCAGTCC-
TGTTGATGTGCCA-39. PCR conditions for both rounds consisted
of an initial denaturation of 94 uC for 2 min, followed by 35 cycles
of 94 uC for 15 s, 55 uC for 30 s and 72 uC for 1 min, and a final
elongation step of 72 uC for 7 min. Specific reverse transcription was
performed for 1 h at 42 uC in a reaction mixture containing 1?5 mM
HV2. For the first round, PCR was carried out with 3 ml cDNA, 1 U
Expand High Fidelity Taq DNA polymerase (Roche Diagnostics),
1?5 mM MgCl2, 0?8 mM dNTP mix, 0?5 mM HV1 and 0?2 mM HV2
in a final volume of 20 ml. For the second round, 3 ml first-round
PCR product and 0?75 mM inner primers were used. A high-fidelity
polymerase was used in order to exclude artefacts due to nucleotide
misincorporations.
HVR1 second-round PCR products were cloned using the TOPO TA
Cloning kit (Invitrogen) according to the manufacturer’s protocol. At
least 10 clones from each transformation were purified with the
TempliPhi Amplification kit (Amersham). Plasmids obtained were
sequenced by fluorescence-based Taq dideoxy terminator cycle
sequencing using the BigDye Terminator Cycle Sequencing Ready
Reaction kit (ABI PRISM; Applied Biosystems) and M13 universal
primers in an automated sequencer (ABI PRISM 310 Genetic Analyser;
Applied Biosystems).
Sequences were compared with GenBank using BLAST to confirm their
identity as HCV HVR1 and deposited in GenBank under accession nos
AY700854–AY700935.
Sequencing of tupaia mRNAs. One microgram of RNA from
tupaia hepatocytes was treated with 1 U DNase I (Gibco-BRL) to
avoid genomic contamination and reverse transcription was per-
formed using MMLV RT enzyme as described above. One-tenth of
the cDNA obtained was subjected to PCR amplification in a final
reaction volume of 30 ml containing 1?5 U BioTaq DNA poly-
merase (Bioline), 1?5 mM MgCl2, 0?3 mM each of sense and anti-
sense primer and 0?5 mM dNTPs (Roche Molecular Biochemicals).
General PCR conditions were as follows: initial denaturation at
94 uC for 1 min, 35–40 cycles of 94 uC for 20 s, 50–60 uC for 15 s
and 72 uC for 15–30 s, and a final extension of 72 uC for 7 min. All
PCRs were performed in a GeneAmp PCR System 2400 (Applied
Biosystems). Primers for amplification of tupaia genes were designed
on the basis of conserved regions in human, mouse and other mam-
mals with known orthologous genes. If non-specific bands were pre-
sent in agarose gels, sequencing of the correct band was performed
to redesign new, more specific primers (see Supplementary Table
available in JGV Online). The design of the majority of primers was
done to guarantee that no genomic DNA could be amplified.
The identity of all amplified mRNA was verified by automatic
sequencing in an ABI PRISM 310 Genetic Analyser (Applied
Biosystems) as described above but using specific primers, followed
by a query against the GenBank database using BLAST. Sequences
of the tupaia genes Myxovirus resistance protein A (MxA), 2959-
oligoadenylate synthetase (2959-OAS), interferon-induced protein
with tetratricopeptide repeats 1 (p56), interferon regulatory factor 1
and 7 (IRF-1 and IRF-7), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), albumin, cytochrome P450 3A4 (CYP3A4), vimentin,
monocyte chemoattractant protein-1 (MCP-1) and chemokine (CXC
motif) ligand 2 (CXCL2/MIP-2) were deposited in GenBank under
accession nos. AY699810–AY699818 and AY701519–AY701520.
Quantification of mRNAs in tupaia hepatocytes by real-time
PCR. Levels of mRNA in the culture were quantified by real-time
PCR using the LightCycler System (Roche Molecular Biochemicals).
Amplification was performed in a 10 ml total volume containing 7 ml
of the PCR mixture [16 LightCycler FastStart Reaction mix with
SYBR Green I (Roche Diagnostics), 6 mM MgCl2, 0?75 mM each
primer) and 3 ml of a 1/10 dilution of cDNA template. PCR conditions
consisted of an initial denaturation at 95 uC for 10 min, followed by
45 cycles of 95 uC for 15 s, 55–65 uC for 5 s and 72 uC for 12 s. Exact
annealing temperatures are shown in Supplementary Table (available
in JGV Online) for each gene. All amplification reactions were per-
formed in triplicate. After the amplification was complete, a final melt-
ing curve was recorded to monitor the dissociation of specific PCR
product. To improve SYBR Green I quantification, a high-temperature
fluorescence measurement was performed (72–94 uC depending on the
gene; see Supplementary Table available in JGV Online). As an internal
control for each sample, PCR amplification of GAPDH was per-
formed. The relative expression of each transcript was expressed using
the formula: 2cpGAPDH2cpgene, where cp is the point at which the fluor-
escence rises appreciably above the background fluorescence.
Electrophoretic mobility shift assay (EMSA). NF-kB-binding
activity was determined by EMSA with a commercial oligonucleotide
containing the kB consensus site (Promega). EMSA was performed
as previously described (Boya et al., 2001). For competition experi-
ments, 7 pmol unlabelled specific kB or non-specific AP-1 oligo-
nucleotides were incubated with nuclear extracts and the labelled
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probe. For supershift experiments, human-specific antibodies against
p50 (20 mg) and p65 (10 mg) and the human non-specific antibody
c-Jun (0?25 mg) (Santa Cruz Biotechnology) were added to the bind-
ing reaction. Samples were electrophoresed and band intensities
were analysed using the Molecular Analyst/PC software (Bio-Rad).
Statistical analysis. Statistical analyses were performed using the
non-parametric Kruskal–Wallis test and Mann–Whitney U-test. All
P values were two-tailed and considered significant for values of
P<0?05. Descriptive data for continuous variables are reported as
medians and interquartile range. Statistical analysis was carried out
using SPSS 9.0 for Windows.
RESULTS
HCV infection of primary tupaia hepatocytes
To study the susceptibility of tupaia hepatocytes to HCV
infection, 20 different tupaia cell cultures were incubated
with sera from different HCV-infected patients. In these
cultures, genomic HCV RNA was examined by nested RT-
PCR of the 59NCR, negative-strand HCV RNA by strand-
specific rTth RT-PCR and the selection of quasispecies in
culture by sequence analysis of HCV HVR1 of the HCV E2
region.
Presence of genomic HCV RNA. Genomic HCV RNA
was detected from 5 to 10 days post-inoculation in 70 %
of primary tupaia hepatocytes cultures (data not shown).
An example of three cultures is shown in Fig. 1. HCV
RNA was not directly detected in any of the culture super-
natants analysed.
As the high sensitivity of nested RT-PCR used to detect
genomic HCV RNA in tupaia hepatocytes could amplify
residual inoculum non-specifically bound to cells, we used
primary hepatocytes from three rats infected under the
same conditions as tupaia hepatocytes as a negative control.
In cultured rat hepatocytes, genomic HCV RNA could be
found 1–3 days after serum incubation (data not shown).
Thus, based on PCR detection of the genomic RNA strand,
it was not possible during the first 3 days of culture to
distinguish signals from the residual inoculum from actual
HCV infection of cultured cells.
Presence of negative-strand HCV RNA. HCV is a
positive-strand RNA virus whose replication occurs via a
negative-strand RNA intermediate. Since the positive
strand is the only form of viral RNA present in the inocu-
lum, detection of negative-strand HCV RNA in infected
cells is indicative of active virus replication (Fournier
et al., 1998). Using the strand-specific rTth RT-PCR assay,
false priming of the incorrect strand is reduced by con-
ducting cDNA synthesis at 70 uC with the thermostable
rTth enzyme (Sangar & Carroll, 1998). To assess the sensi-
tivity and specificity of the method, synthetic positive and
negative strands of HCV RNA encompassing the 59NCR
were used as standards in our assay. Using the negative
strand-specific rTth RT-PCR, we were able to detect 102
molecules of the negative-strand RNA, while a minimum
of 105 molecules of the positive strand was required to
produce a signal (3 logs of specificity). Under these condi-
tions (see Methods), no amplification band was obtained
when using serum samples from infected patients, indicat-
ing that false priming of the positive strand was not
taking place.
In the tupaia hepatocyte cultures with genomic HCV RNA
that was detectable for more than 3 days (nine of 20 cul-
tures), we analysed the negative-strand RNA to confirm HCV
replication. In most cases, the replicative intermediate was
detected at varying time points, from day 1 to 10 (Fig. 1).
Quasispecies analysis. Analyses of the HVR1 deduced
amino acid sequences from primary tupaia hepatocytes
and from the corresponding inocula clearly showed that
HCV undergoes genetic evolution during culture (Fig. 2).
In most cases, the predominant HVR1 amino acid
sequence found in tupaia hepatocyte cultures differed from
the corresponding predominant sequence from the inocu-
lum and this occurred as early as 24 h post-inoculation.
Furthermore, we found similar changes in the sequences
of different HCV-inoculated tupaia hepatocytes cultures
(Fig. 2, amino acids in bold). Interestingly, similar changes
Cultures Days post-inoculation
T3 18455
T5 18419
T5 18450
Genomic HCV RNA
Negative-strand HCV RNA
1   5    10
1    3    5
1    3    5    7
Genomic HCV RNA
Negative-strand HCV RNA
Genomic HCV RNA
Negative-strand HCV RNA ND
ND
Fig. 1. Detection of genomic and negative-strand HCV RNA in
tupaia primary hepatocytes. Cells were incubated 1 day after
plating with different human inocula. Total cellular RNA was
harvested at various times after inoculation and analysed for
HCV genomic and negative-strand RNA using RT-nested PCR
or rTth RT-nested PCR, respectively. Representative examples
of ethidium bromide staining of nested PCR products obtained
by amplification of the 59NCR from three different tupaia cul-
tures are shown for genomic and negative-strand HCV RNA.
All genomic HCV detection assays included negative controls
consisting of tupaia mock-infected cells and water. RNA iso-
lated from HCV-positive serum was used as a positive control.
All negative-strand HCV RNA detection assays included posi-
tive- and negative-strand synthetic HCV RNAs as controls for
strand specificity and sensitivity.
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have also been reported in HCV sequences from tupaia
hepatocyte cultures (Zhao et al., 2002; shown in Fig. 2).
Quasispecies analyses in HCV-infected tupaia hepatocytes
after 3–5 days of culture were not successful since HVR1
could not be amplified in these samples.
Differentiation status of cultured primary hepatocytes.
Our data indicated that tupaia hepatocytes are permissive
to HCV infection but for only a short period, usually last-
ing less than 7–10 days. In order to analyse whether the
loss of HCV replication could be associated with loss of
the differentiated hepatocellular phenotype, we quantified
the expression levels of albumin, CYP3A4 and vimentin.
Albumin and CYP3A4 characterize the mature hepatocyte
phenotype, while vimentin is induced during the dediffer-
entiation process. We found that tupaia hepatocytes
dedifferentiated in culture, exhibiting a rapid decrease in
the mRNA levels of albumin, a progressive reduction of
CYP3A4 transcripts and a progressive increase in vimentin
mRNA. Thus, by day 12, albumin mRNA was reduced to
about 1/100 of initial values, CYP3A4 to less than half
and vimentin expression, which was initially undetectable,
showed strong upregulation (Fig. 3).
Effect of HCV on the antiviral and
proinflammatory status of infected cells
To analyse whether an infectious inoculum could activate
the endogenous interferon system and induce a cellular
stress response in primary tupaia hepatocytes, we deter-
mined the expression of interferon-stimulated genes (ISGs)
and the activation of NF-kB in these cells after incubation
with an HCV-infected serum or a control serum sample.
Induction of ISGs in HCV-infected hepatocytes. Viral
infection stimulates the synthesis of type I interferons,
which induce a diversity of ISGs as a first-line defence
against virus replication. After gene sequencing of the
tupaia ISGs 2959-OAS, MxA, p56, IRF-7 and IRF-1 (see
Methods), we determined their expression levels in HCV-
infected hepatocytes. Determinations were performed in
Fig. 2. Comparison and relative abundance of deduced amino
acid sequences of HVR1 (underlined) obtained from five inocula
(italics) and their corresponding cultures at different time
points. Sequences are shown in decreasing order of abun-
dance. Only amino acids differing from the top sequence are
shown. Amino acids in bold indicate identity with the corre-
sponding amino acid of sequences isolated from HCV-infected
tupaia hepatocyte cultures and with the work of Zhao et al.
(2002).
Fig. 3. Changes over time in culture of hepatocyte differentiation (albumin and CYP3A4) and dedifferentiation (vimentin)
markers in primary tupaia hepatocytes. The level of mRNA expression of each gene was determined by real-time RT-PCR and
normalized to mRNA expression of GAPDH. Bars represent the standard deviation from five independent cultures.
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cells harvested at 2, 4, 6, 12, 16 and 24 h after HCV or
mock infection. As a positive control for ISG induction,
we used tupaia hepatocytes infected with SFV, since we
have previously observed that this virus replicates effi-
ciently in tupaia liver cells (data not shown). We observed
that MxA, p56 and 2959-OAS expression was induced 4 h
after SFV and HCV infection and peaked at 24 h after
infection, while IRF-7 and IRF-1 were induced at 2 h and
peaked at 12 h (data not shown). Fig. 4 shows the relative
expression of the ISG mRNAs in mock-infected, HCV-
infected and SFV-infected hepatocytes at the peak of
expression of these genes. Both viruses were able to signif-
icantly induce ISGs, although HCV induction was sub-
stantially lower than SFV in most cases.
NF-kB activation and induction of chemokines MCP-1
and CXCL2 (MIP-2) in HCV-infected hepatocytes. NF-
kB activation and the resulting nuclear translocation
induces the expression of genes involved in the response
to cellular stress. We analysed NF-kB-binding activity in
the nuclei of tupaia hepatocytes incubated with HCV-
positive or -negative serum. Interestingly, we found that
NF-kB-binding activity was twofold higher (analysed by
densitometry of autoradiograms) in the nuclei of HCV-
infected cells than in control cells (Fig. 5a). As shown in
Fig. 5(a and b), active NF-kB present in tupaia hepatocyte
nuclei was composed mainly of p65/p65 homodimers and
p50/p65 heterodimers, with one minor complex made up
of p65 bound to an unknown element.
The chemokines MCP-1 and CXCL2 (MIP-2) are NF-kB-
responsive genes (Walpen et al., 2001; Wang et al., 2000)
whose expression is upregulated in the liver of patients
with chronic hepatitis C and in other forms of virus-induced
liver damage (Bowen et al., 2002; Muhlbauer et al., 2003).
It is not known whether the virus per se is able to modu-
late the expression of these inflammatory mediators by
parenchymal cells. Therefore, we wished to study whether
chemokine gene expression was induced in tupaia hepato-
cytes after incubation with HCV-positive serum. We found
that the mRNA levels of both MCP-1 and CXCL2 (MIP-2)
were significantly increased at 24 h in tupaia hepatocytes
sustaining HCV replication compared with mock-infected
cells (Fig. 6), indicating that HCV may directly activate
chemokine gene expression in infected liver cells. In these
experiments, we used as controls primary hepatocytes from
rats incubated for 24 h with the infectious serum or with
normal control serum. In these samples, we did not observe
any changes in the expression of NF-kB-inducible chemo-
kines (data not shown), suggesting that the induction of
chemokine expression did not result from the mere
attachment of virions to the cell membrane, but rather
from the penetration and replication of the virus in the cell.
DISCUSSION
In a previous study, we have shown that tupaias (T. belangeri
chinensis) can be infected with HCV, although the infec-
tion is barely productive and needs to be facilitated by
Fig. 4. Quantification of ISG mRNA expression in primary tupaia hepatocytes infected with HCV or SFV or mock-infected,
using real-time RT-PCR and the LightCycler System, as described in Methods. Results were normalized against levels of
GAPDH mRNA. (a) Relative expression of MxA, 2959-OAS and p56 at 24 h. (b) Relative expression of IRF-1 and IRF-7 at
12 h after infection. Data correspond to triplicates of three mock-infected cases, six HCV-infected cases and three SFV-
infected case. NS, Not significant.
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immunosuppression with total body irradiation (Xie et al.,
1998). In the present work, we have shown that HCV can
infect and replicate in cultured primary tupaia hepato-
cytes, confirming the findings by Zhao et al. (2002), who
demonstrated the possibility of culturing HCV using pri-
mary hepatocytes from these animals.
In our in vitro system, cells were maintained overnight in the
presence of the infectious sample (50 ml in 1 ml culture
medium) and then washed repeatedly and cultured for
3 weeks, changing the medium every 2–3 days. Despite
careful washing, the viral genome from the inoculum can
remain non-specifically bound to the cells for a period of
time. Using control rat hepatocytes, we found that the
genomic HCV RNA strand could be detected for a
maximum of 3 days. In contrast, HCV RNA could be
detected from 5 to 10 days in most of the tupaia hepato-
cyte cultures. Moreover, the replicative intermediate, which
is not found in the inoculum, could be detected in tupaia
hepatocytes at various time points in different culture
experiments. However, the level of HCV replication in
tupaia liver cells was low and we were not able to detect
genomic HCV RNA by RT-PCR in the culture supernatants.
These data are in agreement with reports of HCV infection
of adult human primary hepatocytes (Castet et al., 2002;
Fournier et al., 1998) or human dendritic cells (Navas et al.,
2002), where no direct evidence for release of virus particles
in the culture medium was observed. It seems, therefore,
that the secretion of viral particles to the extracellular
environment is minimal and, indeed, Zhao et al. (2002)
were able to detect HCV RNA in the supernatant of tupaia
hepatocytes only after vigorous concentration of the virions
present in the medium.
As mentioned above, in our system the presence of HCV
RNA in cultured cells was limited to about 7 days (and never
beyond 10 days). Cell viability was well preserved for longer
periods, but cultured cells experienced a dedifferentiation
process manifested by a rapid decline in the expression of
hepatocyte-specific genes such as albumin and CYP3A4 and
an increase in the dedifferentiation marker vimentin. It
seems possible that the loss of the differentiated phenotype
Fig. 5. NF-kB-binding activity in tupaia hepatocytes assayed
by EMSA. (a) NF-kB activation of p65/p65 and p50/p65 was
observed in tupaia primary hepatocytes infected with HCV (+)
compared with mock-infected cells (”). (b) Supershift and com-
petition experiments were performed to identify NF-kB subunits
in tupaia hepatocytes and the specificity of the bands. Lane 1,
nuclear extract from tupaia cultured hepatocytes incubated with
kB-labelled probe (control lane); lanes 2–4, supershift assay
with antibodies specific for different members of the NF-kB
family (lane 2, anti-p50; lane 3, anti-p65) and the non-specific
antibody c-Jun (lane 4). Complexes I, II and III shown in lane 1
are supershifted with anti-p65 antibody (lane 3) and complex II
is supershifted with anti-p50 antibody (lane 2), indicating that
complex I is composed of p65/p65 homodimers, complex II of
p50/p65 heterodimers and complex III of p65 and another
uncharacterized subunit. Lanes 5 and 6, competition experi-
ments. Unlabelled specific kB (lane 5) or non-specific AP-1
(lane 6) oligonucleotides were incubated with nuclear extracts
and the labelled probe. Specific bands (complexes I, II and III)
showed decreased intensity in lane 5 with respect to lane 6.
The non-specific band (complex IV) showed little change in
intensity in either lanes.
Fig. 6. Quantification of chemokines MCP-1 and CXCL2 (MIP-
2) mRNA expression in mock-infected and HCV-infected tupaia
hepatocytes. Results are represented as mRNA relative expres-
sion after normalization of the data to the expression level of
the GAPDH mRNA. Data correspond to triplicates of three
mock-infected cases and six HCV-infected cases.
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might be responsible for the cessation of virus replication.
The role of the hepatocyte phenotype in maintaining HCV
in culture has been suggested by other authors (Iacovacci
et al., 1997; Rumin et al., 1999). Rumin et al. (1999) reported
that HCV replication in cultured human hepatocytes was
strongly dependent on the composition of the culture
medium. These studies showed that the presence of DMSO,
hydrocortisone and normal human serum (as in the con-
ditions used in the present study) resulted in more efficient
HCV replication. It seems possible that the development
of improved methods directed towards preserving both
viability and differentiation of cultured hepatocytes could
enhance the ability of the cells to sustain HCV replication.
Characterization of HCV variants isolated from tupaia
hepatocytes and from the corresponding inocula showed
that the virus undergoes genetic evolution in culture. It is
important to note that some of the predominant variants
detected in tupaia hepatocytes was not found in the inocula,
a finding that confirms the ability of HCV to replicate
in tupaia liver cells. Furthermore, we found coincident
changes in cultures of cells infected with different inocula.
These same specific amino acid changes were also found by
Zhao et al. (2002), suggesting a strong selection favouring
sequences able to adapt to the biology of tupaia cells. We
noticed that this adaptation occurred very early during
culture, being observed during the first 24 h after infection
of the cells, indicating a surprising plasticity of the viral
quasispecies. The selection of specific variants for different
cell types has already been reported by several groups who
described lymphotropic and hepatotropic HCV quasispecies
in primary cultures (Laporte et al., 2003; Navas et al., 2002),
as well as in cell lines (Kato et al., 1998; Nakajima et al.,
1996). In our study, in addition to the selection of tupaia-
tropic HCV variants, we found a marked decrease in
quasispecies complexity over time in culture. This fact has
also been described for HCV propagated in primary human
hepatocytes (Rumin et al., 1999). Nevertheless, this group
found that most mutations in the HVR1 region were silent,
occurring in the third codon position, while in tupaia
hepatocytes the nucleotide changes observed were usually
accompanied by amino acid changes, suggesting a strong
evolution of the viral genome in the tupaia cells.
In the present work, we showed that HCV infection of
cultured liver cells could increase the expression of the
ISGs 2959-OAS, MxA, p56, IRF-7 and IRF1, further sup-
porting the existence of a productive infection of tupaia
hepatocytes in culture. However, the ability of HCV to
induce interferon-sensitive genes was blunted compared
with that of SFV. This mild activation of the interferon
system may be due to either the low level of replication
of HCV in tupaia hepatocytes or to an intrinsic ability of
the virus to blunt the interferon response.
We also provided evidence that HCV can activate NF-kB in
isolated hepatocytes. Activation of this transcription factor
has been detected in cells transfected with plasmids encod-
ing NS5 and in cells stably expressing HCV subgenomic
replicons (Gong et al., 2001; Waris et al., 2003). However,
under these conditions the intracellular levels of viral
proteins are very high and are not representative of those
found in naturally infected hepatocytes. In natural infection,
we found that NF-kB could be detected in hepatocyte nuclei
in liver biopsies of patients with chronic hepatitis C (Boya
et al., 2001). However, it was not clear whether the viral
infection per se or the effect of proinflammatory cytokines
produced by the mononuclear cells of the inflammatory
infiltrate were responsible for NF-kB activation in hepato-
cytes. Our present data indicate that HCV can directly
activate NF-kB in hepatocytes and that this effect is followed
by upregulation of NF-kB-responsive genes such as MCP-1
and CXCL2 (MIP-2). Expression of these chemokines by
infected cells would induce a proinflammatory status in
HCV-infected cells and attraction of immune effectors to
the liver. This effect may play a role in the initiation of the
inflammatory response and in the immune elimination of
the infected cells.
ACKNOWLEDGEMENTS
We are grateful to P. Berthillon and C. Trepo (INSERM U271, Lyon,
France) for their help in culture and HCV infection of tupaia primary
hepatocytes and for their excellent technical assistance at the beginning
of the study. This work was supported in part by grants from the
European Union (Ref QLRT-1999-00356), SAF 2002-037 from the
Ministry of Science and Technology (to J. P.), the UTE project CIMA
and Instituto Carlos III C03/C02. A. G. was a recipient of a fellowship
from the Foundation for Applied Medical Research (University of
Navarra, Spain) and the Foundation Gangoiti (Bilbao, Spain).
REFERENCES
Barth, H., Cerino, R., Arcuri, M. & 12 other authors (2005).
Scavenger receptor class B type I and hepatitis C virus infection of
primary Tupaia hepatocytes. J Virol 79, 5774–5785.
Bowen, G. P., Borgland, S. L., Lam, M., Libermann, T. A., Wong, N. C.
& Muruve, D. A. (2002). Adenovirus vector-induced inflammation:
capsid-dependent induction of the C-C chemokine RANTES requires
NF-kB. Hum Gene Ther 13, 367–379.
Boya, P., Larrea, E., Sola, I., Majano, P. L., Jimenez, C., Civeira, M. P.
& Prieto, J. (2001). Nuclear factor-kB in the liver of patients with
chronic hepatitis C: decreased RelA expression is associated with
enhanced fibrosis progression. Hepatology 34, 1041–1048.
Bukh, J., Pietschmann, T., Lohmann, V. & 7 other authors (2002).
Mutations that permit efficient replication of hepatitis C virus RNA
in Huh-7 cells prevent productive replication in chimpanzees. Proc
Natl Acad Sci U S A 99, 14416–14421.
Castet, V., Fournier, C., Soulier, A., Brillet, R., Coste, J., Larrey, D.,
Dhumeaux, D., Maurel, P. & Pawlotsky, J. M. (2002). Alpha
interferon inhibits hepatitis C virus replication in primary human
hepatocytes infected in vitro. J Virol 76, 8189–8199.
Cribier, B., Schmitt, C., Bingen, A., Kirn, A. & Keller, F. (1995). In
vitro infection of peripheral blood mononuclear cells by hepatitis C
virus. J Gen Virol 76, 2485–2491.
Farci, P. & Purcell, R. H. (2000). Clinical significance of
hepatitis C virus genotypes and quasispecies. Semin Liver Dis 20,
103–126.
3072 Journal of General Virology 86
A. Guitart and others
Forns, X., Thimme, R., Govindarajan, S., Emerson, S. U.,
Purcell, R. H., Chisari, F. V. & Bukh, J. (2000). Hepatitis C virus
lacking the hypervariable region 1 of the second envelope protein is
infectious and causes acute resolving or persistent infection in
chimpanzees. Proc Natl Acad Sci U S A 97, 13318–13323.
Fournier, C., Sureau, C., Coste, J., Ducos, J., Pageaux, G., Larrey, D.,
Domergue, J. & Maurel, P. (1998). In vitro infection of adult normal
human hepatocytes in primary culture by hepatitis C virus. J Gen
Virol 79, 2367–2374.
Gong, G., Waris, G., Tanveer, R. & Siddiqui, A. (2001). Human
hepatitis C virus NS5A protein alters intracellular calcium levels,
induces oxidative stress, and activates STAT-3 and NF-kB. Proc Natl
Acad Sci U S A 98, 9599–9604.
Iacovacci, S., Bertolini, L., Manzin, A., Valli, M. B., Battaglia, M.,
Ponzetto, A., Clementi, M. & Carloni, G. (1997). Quantitation
of hepatitis C virus RNA production in two human bone
marrow-derived B-cell lines infected in vitro. Res Virol 148,
147–151.
Kato, N., Ikeda, M., Sugiyama, K., Mizutani, T., Tanaka, T. &
Shimotohno, K. (1998). Hepatitis C virus population dynamics in
human lymphocytes and hepatocytes infected in vitro. J Gen Virol 79,
1859–1869.
Lanford, R. E., Sureau, C., Jacob, J. R., White, R. & Fuerst, T. R.
(1994). Demonstration of in vitro infection of chimpanzee
hepatocytes with hepatitis C virus using strand-specific RT/PCR.
Virology 202, 606–614.
Lanford, R. E., Chavez, D., Chisari, F. V. & Sureau, C. (1995). Lack of
detection of negative-strand hepatitis C virus RNA in peripheral
blood mononuclear cells and other extrahepatic tissues by the
highly strand-specific rTth reverse transcriptase PCR. J Virol 69,
8079–8083.
Laporte, J., Bain, C., Maurel, P., Inchauspe, G., Agut, H. &
Cahour, A. (2003). Differential distribution and internal transla-
tion efficiency of hepatitis C virus quasispecies present in dendritic
and liver cells. Blood 101, 52–57.
Li, Q., Ding, M. & Wang, H. (1995). The infection of hepatitis D virus
in adult tupaia. Zhonghua Yi Xue Za Zhi 75, 611–613, 639–640 (in
Chinese).
Liljestrom, P. & Garoff, H. (1991). A new generation of animal cell
expression vectors based on the Semliki Forest virus replicon.
Biotechnology 9, 1356–1361.
Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann,
L. & Bartenschlager, R. (1999). Replication of subgenomic
hepatitis C virus RNAs in a hepatoma cell line. Science 285,
110–113.
Lopez-Labrador, F. X., Ampurdanes, S., Gimenez-Barcons, M.,
Guilera, M., Costa, J., Jimenez de Anta, M. T., Sanchez-Tapias, J. M.,
Rodes, J. & Saiz, J. C. (1999). Relationship of the genomic
complexity of hepatitis C virus with liver disease severity and
response to interferon in patients with chronic HCV genotype 1b
infection [correction of interferon]. Hepatology 29, 897–903; erratum
29, 1915.
Manzin, A., Solforosi, L., Petrelli, E., Macarri, G., Tosone, G.,
Piazza, M. & Clementi, M. (1998). Evolution of hypervariable
region 1 of hepatitis C virus in primary infection. J Virol 72,
6271–6276.
Martin, R. D. (1990). Are tree-shrews primates? In Primate Origins
and Evolution: a Phylogenetic Reconstruction, pp. 191–213. Edited by
R. D. Martin. London: Chapman & Hall.
Muhlbauer, M., Bosserhoff, A. K., Hartmann, A., Thasler, W. E.,
Weiss, T. S., Herfarth, H., Lock, G., Scholmerich, J. & Hellerbrand,
C. (2003). A novel MCP-1 gene polymorphism is associated with
hepatic MCP-1 expression and severity of HCV-related liver disease.
Gastroenterology 125, 1085–1093.
Nakajima, N., Hijikata, M., Yoshikura, H. & Shimizu, Y. K. (1996).
Characterization of long-term cultures of hepatitis C virus. J Virol
70, 3325–3329.
Navas, M. C., Fuchs, A., Schvoerer, E., Bohbot, A., Aubertin, A. M. &
Stoll-Keller, F. (2002). Dendritic cell susceptibility to hepatitis C
virus genotype 1 infection. J Med Virol 67, 152–161.
Pessoa, M. G., Bzowej, N., Berenguer, M., Phung, Y., Kim, M.,
Ferrell, L., Hassoba, H. & Wright, T. L. (1999). Evolution of hepatitis
C virus quasispecies in patients with severe cholestatic hepatitis after
liver transplantation. Hepatology 30, 1513–1520.
Radkowski, M., Bednarska, A., Horban, A., Stanczak, J., Wilkinson,
J., Adair, D. M., Nowicki, M., Rakela, J. & Laskus, T. (2004). Infection
of primary human macrophages with hepatitis C virus in vitro:
induction of tumour necrosis factor-a and interleukin 8. J Gen Virol
85, 47–59.
Robertson, B., Myers, G., Howard, C. & 14 other authors (1998).
Classification, nomenclature, and database development for hepatitis
C virus (HCV) and related viruses: proposals for standardiza-
tion. International Committee on Virus Taxonomy. Arch Virol 143,
2493–2503.
Rumin, S., Gripon, P., Le Seyec, J., Corral-Debrinski, M. & Guguen-
Guillouzo, C. (1996). Long-term productive episomal hepatitis B
virus replication in primary cultures of adult human hepatocytes
infected in vitro. J Viral Hepat 3, 227–238.
Rumin, S., Berthillon, P., Tanaka, E. & 8 other authors (1999).
Dynamic analysis of hepatitis C virus replication and quasispecies
selection in long-term cultures of adult human hepatocytes infected
in vitro. J Gen Virol 80, 3007–3018.
Sangar, D. V. & Carroll, A. R. (1998). A tale of two strands: reverse-
transcriptase polymerase chain reaction detection of hepatitis C virus
replication. Hepatology 28, 1173–1176.
Su, A. I., Pezacki, J. P., Wodicka, L. & 8 other authors (2002).
Genomic analysis of the host response to hepatitis C virus infection.
Proc Natl Acad Sci U S A 99, 15669–15674.
Wakita, T., Pietschmann, T., Kato, T. & 8 other authors (2005).
Production of infectious hepatitis C virus in tissue culture from a
cloned viral genome. Nat Med 11, 791–796.
Walpen, S., Beck, K. F., Schaefer, L., Raslik, I., Eberhardt, W.,
Schaefer, R. M. & Pfeilschifter, J. (2001). Nitric oxide induces MIP-
2 transcription in rat renal mesangial cells and in a rat model of
glomerulonephritis. FASEB J 15, 571–573.
Walter, E., Keist, R., Niederost, B., Pult, I. & Blum, H. E. (1996).
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
Hepatology 24, 1–5.
Wang, Y., Rangan, G. K., Goodwin, B., Tay, Y. C. & Harris, D. C.
(2000). Lipopolysaccharide-induced MCP-1 gene expression in rat
tubular epithelial cells is nuclear factor-kB dependent. Kidney Int 57,
2011–2022.
Waris, G., Livolsi, A., Imbert, V., Peyron, J. F. & Siddiqui, A. (2003).
Hepatitis C virus NS5A and subgenomic replicon activate NF-kB via
tyrosine phosphorylation of IkBa and its degradation by calpain
protease. J Biol Chem 278, 40778–40787.
Weiner, A. J., Brauer, M. J. & Rosenblatt, J. (1991).
Variable and hypervariable domains are found in the regions
of HCV corresponding to the flavivirus envelope and NS1
proteins and the pestivirus envelope glycoproteins. Virology 180,
842–848.
Xie, Z. C., Riezu-Boj, J. I., Lasarte, J. J., Guillen, J., Su, J. H., Civeira,
M. P. & Prieto, J. (1998). Transmission of hepatitis C virus infection
to tree shrews. Virology 244, 513–520.
http://vir.sgmjournals.org 3073
HCV infection in primary tupaia hepatocytes
Yan, R. Q., Su, J. J., Huang, D. R., Gan, Y. C., Yang, C. & Huang, G. H.
(1996). Human hepatitis B virus and hepatocellular carcinoma. I.
Experimental infection of tree shrews with hepatitis B virus. J Cancer
Res Clin Oncol 122, 283–288.
Zhan, M. Y., Liu, C. B., Li, C. M. & 11 other authors (1981). A
preliminary study of hepatitis A virus in Chinese tupaia [author’s
translation]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 3, 148–152 (in
Chinese).
Zhao, X., Tang, Z. Y., Klumpp, B., Wolff-Vorbeck, G., Barth, H., Levy,
S., von Weizsacker, F., Blum, H. E. & Baumert, T. F. (2002). Primary
hepatocytes of Tupaia belangeri as a potential model for hepatitis C
virus infection. J Clin Invest 109, 221–232.
3074 Journal of General Virology 86
A. Guitart and others
